AbbVie announced topline results from a Phase 2 study of upadacitinib given alone or as combination therapy (ABBV-599) with a Bruton's Tyrosine Kinase inhibitor (elsubrutinib,...
Aquavit Pharmaceuticals, Inc. (Aquavit), a biotechnology company focused on the development of a first-of-its-kind microchannel drug delivery technology, announced that the company's technology patent...
The Chemours Company , a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, announces...
Amprius Technologies, Inc, a leader in next-generation lithium-ion batteries with its Silicon Anode Platform, is once again raising the bar with the verification of...
Ubiquitous Energy, a next-generation technology company developing truly transparent solar technology for architectural glass, is excited to announce that it has been invited to...
